Intravenous ibandronate in men with osteoporosis: an open pilot study over 2 years (Q44689194)

5 December 2017

Intravenous ibandronate in men with osteoporosis: an open pilot study over 2 years (English)

1 reference

5 December 2017

0 references

O Lamy

1

1 reference

5 December 2017

L Sandini

2

1 reference

5 December 2017

I Pache

3

1 reference

5 December 2017

S Fatio

4

1 reference

5 December 2017

J Burnand

5

1 reference

5 December 2017

P Burckhardt

6

1 reference

5 December 2017

1 August 2003

1 reference

Journal of Endocrinological Investigation

5 December 2017

1 reference

5 December 2017

26

1 reference

5 December 2017

8

1 reference

5 December 2017

728-732

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03347354

5 December 2017

0 references

cites work

Hip fractures in the elderly: a world-wide projection

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Management of male osteoporosis: report of the UK Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Esophagitis associated with the use of alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347354

Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14669826

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14669826

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03347354

1 reference

5 December 2017

1 reference